Double-Blind Prospective Randomized Controlled Trial of Dopamine Versus Epinephrine as First-Line Vasoactive Drugs in Pediatric Septic Shock

Imagem de Miniatura
Arquivos
art_VENTURA_DoubleBlind_Prospective_Randomized_Controlled_Trial_of_Dopamine_Versus_2015.PDF (619.9 KB)
Citações na Scopus
137
Tipo de produção
article
Data de publicação
2015
Editora
LIPPINCOTT WILLIAMS & WILKINS
DOI
Indexadores
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Autores
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
CRITICAL CARE MEDICINE, v.43, n.11, p.2292-2302, 2015
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objectives: The primary outcome was to compare the effects of dopamine or epinephrine in severe sepsis on 28-day mortality; secondary outcomes were the rate of healthcare-associated infection, the need for other vasoactive drugs, and the multiple organ dysfunction score. Design: Double-blind, prospective, randomized controlled trial from February 1, 2009, to July 31, 2013. Setting: PICU, Hospital Universitario da Universidade de SAo Paulo, Brazil. Patients: Consecutive children who are 1 month to 15 years old and met the clinical criteria for fluid-refractory septic shock. Exclusions were receiving vasoactive drug(s) prior to hospital admission, having known cardiac disease, having already participated in the trial during the same hospital stay, refusing to participate, or having do-not-resuscitate orders. Interventions: Patients were randomly assigned to receive either dopamine (5-10 g/kg/min) or epinephrine (0.1-0.3 g/kg/min) through a peripheral or intraosseous line. Patients not reaching predefined stabilization criteria after the maximum dose were classified as treatment failure, at which point the attending physician gradually stopped the study drug and started another catecholamine. Measurements and Main Results: Physiologic and laboratory data were recorded. Baseline characteristics were described as proportions and mean ( sd) and compared using appropriate statistical tests. Multiple regression analysis was performed, and statistical significance was defined as a p value of less than 0.05. Baseline characteristics and therapeutic interventions for the 120 children enrolled (63, dopamine; 57, epinephrine) were similar. There were 17 deaths (14.2%): 13 (20.6%) in the dopamine group and four (7%) in the epinephrine group (p = 0.033). Dopamine was associated with death (odds ratio, 6.5; 95% CI, 1.1-37.8; p = 0.037) and healthcare-associated infection (odds ratio, 67.7; 95% CI, 5.0-910.8; p = 0.001). The use of epinephrine was associated with a survival odds ratio of 6.49. Conclusions: Dopamine was associated with an increased risk of death and healthcare-associated infection. Early administration of peripheral or intraosseous epinephrine was associated with increased survival in this population. Limitations should be observed while interpreting these results.
Palavras-chave
children, dopamine, epinephrine, mortality, septic shock, vasoactive drug
URI
https://observatorio.fm.usp.br/handle/OPI/12429
Referências
  1. Filippi L, 2007, ARCH DIS CHILD-FETAL, V92, P367, DOI 10.1136/adc.2006.098566
  2. Oliveira CF, 2008, PEDIATR EMERG CARE, V24, P810, DOI 10.1097/PEC.0b013e31818e9f3a
  3. Levy B, 2005, LANCET, V365, P871, DOI 10.1016/S0140-6736(05)71045-X
  4. Wolfler A, 2008, INTENS CARE MED, V34, P1690, DOI 10.1007/s00134-008-1148-y
  5. Sakr Y, 2006, CRIT CARE MED, V34, P589, DOI 10.1097/01.CCM.0000201896.45809.E3
  6. Hartman ME, 2013, PEDIATR CRIT CARE ME, V14, P686, DOI 10.1097/PCC.0b013e3182917fad
  7. Levy B, 2003, INTENS CARE MED, V29, P292, DOI 10.1007/s00134-002-1611-0
  8. FELTES TF, 1994, CRIT CARE MED, V22, P1647
  9. Brierley J, 2009, CRIT CARE MED, V37, P666, DOI 10.1097/CCM.0b013e31819323c6
  10. Povoa PR, 2009, CRIT CARE MED, V37, P410, DOI 10.1097/CCM.0b013e3181958b1c
  11. Leteurtre S, 2003, LANCET, V362, P192, DOI 10.1016/S0140-6736(03)13908-6
  12. Carcillo JA, 2002, CRIT CARE MED, V30, P1365, DOI 10.1097/00003246-200206000-00040
  13. Larsen GY, 2011, PEDIATRICS, V127, pE1585, DOI 10.1542/peds.2010-3513
  14. Debaveye YA, 2004, ANESTH ANALG, V98, P461, DOI 10.1213/01.ANE.0000096188.35789.37
  15. Cheung PY, 2001, CRIT CARE, V5, P158, DOI 10.1186/cc1016
  16. VANDENBERGHE G, 1994, CRIT CARE MED, V22, P1747
  17. De Backer D, 2003, CRIT CARE MED, V31, P1659, DOI 10.1097/01.CCM.0000063045.77339.B6
  18. LeTulzo Y, 1997, INTENS CARE MED, V23, P664
  19. Osborn D, 2002, J PEDIATR-US, V140, P183, DOI 10.1067/mpd.2002.120834
  20. Paul R, 2014, PEDIATRICS, V133, pE1358, DOI 10.1542/peds.2013-3871
  21. BARRINGTON KJ, 1995, CRIT CARE MED, V23, P740, DOI 10.1097/00003246-199504000-00024
  22. Joyce JJ, 2004, AM J CARDIOL, V93, P797, DOI 10.1016/j.amjcard.2003.11.063
  23. WERNOVSKY G, 1995, CIRCULATION, V92, P2226
  24. Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002
  25. Day NPJ, 1996, LANCET, V348, P219, DOI 10.1016/S0140-6736(96)09096-4
  26. Ninis N, 2005, BRIT MED J, V330, P1475, DOI 10.1136/bmj.330.7506.1475
  27. Inwald DP, 2009, ARCH DIS CHILD, V94, P348, DOI 10.1136/adc.2008.153064
  28. Froehlich CD, 2009, CRIT CARE MED, V37, P1090, DOI 10.1097/CCM.0b013e31819b570e
  29. Osborn DA, 2007, PEDIATRICS, V120, P372, DOI 10.1542/peds.2006-3398
  30. Carlbom DJ, 2007, CRIT CARE MED, V35, P2525, DOI 10.1097/01.CCM.0000281855.57917.C8
  31. Ceneviva G, 1998, PEDIATRICS, V102, part. no., DOI 10.1542/peds.102.2.e19
  32. Träger Karl, 2003, Curr Opin Crit Care, V9, P271
  33. MARIJIANOWSKI MMH, 1994, J AM COLL CARDIOL, V23, P1204
  34. CARCILLO JA, 1989, CRIT CARE MED, V17, P12, DOI 10.1097/00003246-198901000-00004
  35. PARKER MM, 1984, ANN INTERN MED, V100, P483
  36. Beck GC, 2004, CRIT CARE, V8, P485, DOI 10.1186/cc2879
  37. De Backer D, 2012, CRIT CARE MED, V40, P725, DOI 10.1097/CCM.0b013e31823778ee
  38. Nadel S, 1998, J ACCID EMERG MED, V15, P298
  39. Han YY, 2003, PEDIATRICS, V112, P793, DOI 10.1542/peds.112.4.793
  40. Beale Richard J, 2004, Crit Care Med, V32, pS455, DOI 10.1097/01.CCM.0000142909.86238.B1
  41. Jaramillo-Bustamante JC, 2012, PEDIATR CRIT CARE ME, V13, P501, DOI 10.1097/PCC.0b013e31823c980f
  42. Phillipos EZ, 1996, PEDIATR RES, V39, P238, DOI 10.1203/00006450-199604001-01437
  43. Raj S, 2014, J PEDIATR-US, V164, P72, DOI 10.1016/j.jpeds.2013.09.027
  44. Wheeler D. S., 2011, OPEN INFLAMM J S1, V4, P4

Coleções
Artigos e Materiais de Revistas Científicas - FM/MPE
Artigos e Materiais de Revistas Científicas - HU